John C. Schoen

SAN DIEGO — Gerald W. Smetana, MD, MACP, provided an update on three new treatments that are important to primary care physicians.Specifically, these include the COVID-19 antiviral Paxlovid (nirmatrelvir/ritonavir, Pfizer) — which is technically only authorized by the FDA for emergency use but is expected to receive approval soon — along with Mounjaro (tirzepatide, Lilly), the

WASHINGTON — In this video interview, Karen M. Krueger, MD, assistant professor of infectious diseases at Northwestern Medicine, talks about the WHO’s Global Arbovirus Initiative, which launched earlier this year.

WASHINGTON — Three late-breaking studies offered a promising glimpse of respiratory syncytial virus vaccines in the pipeline for older adults — including the RSVPreF3 OA vaccine, which showed an overall vaccine efficacy of about 83%.

In this video, David W. Kimberlin, MD, the program director of the Infectious Diseases in Children Symposium, discusses important changes in the AAP’s 2021 Red Book.  

A large survey of reproductive endocrinology and infertility clinics in the United States showed that many were satisfied with telehealth services and plan to continue offering them after the COVID-19 pandemic ends. A separate survey of patients also showed widespread satisfaction with the technolog…